Following the landmark SPRINT trial, there is a growing body of evidence for reducing systolic blood pressure targets, resulting in the development of new US guidelines. However, this has led to many questions about the impact of such fundamental changes in blood pressure management, and whether they should be implemented in other constituencies. Two new studies assess the benefits and costs of incorporating these more aggressive goals into clinical practice.
from Latest Science News -- ScienceDaily https://ift.tt/2rn1Uyu
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment